MBX Biosciences, Inc. Common Stock (MBX) Research Hub

MBX Biosciences, Inc. Common Stock (MBX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 59.02 USD (-6.18%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -26.50, market cap 1.93B. This hub links to the full technical, earnings and options research available for MBX.

Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close59.02 USD (-6.18%)
52-week range35.58 USD – 71.12 USD
Trend regimeRange
14-day RSI30.3 (Bearish)
Trailing P/E-26.50
Market cap1.93B
Dividend yield0.00%
Next earnings2026-08-06

Available research for MBX

Earnings

MBX earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Buy, P/E -26.50. Updated 2026-07-23.

Options: Covered Call

Covered Call on MBX: how it works, illustrative setup around the real 59.02 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on MBX: how it works, illustrative setup around the real 59.02 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on MBX: how it works, illustrative setup around the real 59.02 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

MBX technical analysis: range, last 59.02 USD, RSI 30.3, 52w range 35.58 USD–71.12 USD, real support/resistance. Updated 2026-09-11.

Frequently asked questions

What sector is MBX in?

MBX Biosciences, Inc. Common Stock (MBX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is MBX in an uptrend or downtrend?

As of 2026-09-11, MBX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is MBX's trailing P/E ratio?

MBX's trailing P/E is -26.50, with a market cap of 1.93B. See the earnings research page for full valuation detail.

When does MBX next report earnings?

MBX is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -0.68 USD.